Verde Bio Holdings Stock Performance
| APHD Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Verde Bio are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Verde Bio Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, Verde Bio is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 1631.00 |
Verde |
Verde Bio Relative Risk vs. Return Landscape
If you would invest 0.01 in Verde Bio Holdings on August 26, 2024 and sell it today you would earn a total of 0.00 from holding Verde Bio Holdings or generate 0.0% return on investment over 90 days. Verde Bio Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Verde, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Verde Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verde Bio's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Verde Bio Holdings, and traders can use it to determine the average amount a Verde Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| APHD |
Based on monthly moving average Verde Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verde Bio by adding Verde Bio to a well-diversified portfolio.
Verde Bio Fundamentals Growth
Verde Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Verde Bio, and Verde Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Verde Pink Sheet performance.
| Return On Asset | -0.16 | |||
| Operating Margin | (0.99) % | |||
| Current Valuation | 286.8 K | |||
| Shares Outstanding | 254.04 K | |||
| Price To Earning | (0.20) X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 456.04 K | |||
| EBITDA | (1.27 M) | |||
| Cash And Equivalents | 126.02 K | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 1.07 M | |||
| Book Value Per Share | (5.54) X | |||
| Cash Flow From Operations | (177.75 K) | |||
| Earnings Per Share | (1.26) X | |||
| Total Asset | 1.63 K | |||
| Retained Earnings | (2.43 M) | |||
| Current Asset | 28 K | |||
| Current Liabilities | 986 K | |||
About Verde Bio Performance
By analyzing Verde Bio's fundamental ratios, stakeholders can gain valuable insights into Verde Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Verde Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Verde Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. Apogee 21 Holdings, Inc. was founded in 2005 and is based in Wheat Ridge, Colorado. Apogee 21 operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.Things to note about Verde Bio Holdings performance evaluation
Checking the ongoing alerts about Verde Bio for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Verde Bio Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Verde Bio Holdings generated a negative expected return over the last 90 days | |
| Verde Bio Holdings has some characteristics of a very speculative penny stock | |
| Verde Bio Holdings currently holds 1.07 M in liabilities. Verde Bio Holdings has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Verde Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Verde Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Verde Bio Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Verde to invest in growth at high rates of return. When we think about Verde Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 456.04 K. Net Loss for the year was (1.58 M) with profit before overhead, payroll, taxes, and interest of 11.54 K. | |
| Verde Bio Holdings currently holds about 126.02 K in cash with (177.75 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: EFSH Stock Plummets to 52-Week Low at 0. Amid Market Struggles - Investing.com India |
- Analyzing Verde Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Verde Bio's stock is overvalued or undervalued compared to its peers.
- Examining Verde Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Verde Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Verde Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Verde Bio's pink sheet. These opinions can provide insight into Verde Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Verde Pink Sheet analysis
When running Verde Bio's price analysis, check to measure Verde Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verde Bio is operating at the current time. Most of Verde Bio's value examination focuses on studying past and present price action to predict the probability of Verde Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verde Bio's price. Additionally, you may evaluate how the addition of Verde Bio to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |